These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 19527714)

  • 1. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
    Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
    Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model.
    Muregi FW; Kino H; Ishih A
    Exp Parasitol; 2008 Nov; 120(3):286-9. PubMed ID: 18789931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimetabolites of folic acid metabolism with chemotherapeutic activity against rodent malaria (Plasmodium vinckei)].
    Heischkeil R
    Z Tropenmed Parasitol; 1973 Dec; 24(4):505-16. PubMed ID: 4778588
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria. 18. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 5. The blood schizontocidal action of some newer sulphonamides.
    Peters W
    Ann Trop Med Parasitol; 1973 Jun; 67(2):155-67. PubMed ID: 4578936
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.
    Nduati E; Diriye A; Ommeh S; Mwai L; Kiara S; Masseno V; Kokwaro G; Nzila A
    Parasitol Res; 2008 May; 102(6):1227-34. PubMed ID: 18259776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate.
    Nzila A; Rottmann M; Chitnumsub P; Kiara SM; Kamchonwongpaisan S; Maneeruttanarungroj C; Taweechai S; Yeung BK; Goh A; Lakshminarayana SB; Zou B; Wong J; Ma NL; Weaver M; Keller TH; Dartois V; Wittlin S; Brun R; Yuthavong Y; Diagana TT
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2603-10. PubMed ID: 20350951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
    Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
    Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical aspects of drug action and resistance in malaria parasites.
    Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.
    Knight DJ; Peters W
    Ann Trop Med Parasitol; 1980 Aug; 74(4):393-404. PubMed ID: 7006531
    [No Abstract]   [Full Text] [Related]  

  • 16. The design of original antimalarial drugs. An example of phospholipid metabolism.
    Vial HJ; Ancelin ML; Elabbadi N; Gumila C; Bonnet H; Jeong YH; Philippot J; Calas M; Portefaix P; Piquet G
    Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of drug-resistant malaria: animal experiments].
    Benazet F; Godard C
    Bull World Health Organ; 1974; 50(3-4):235-42. PubMed ID: 4613506
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model.
    Shinondo CJ; Lanners HN; Lowrie RC; Wiser MF
    Exp Parasitol; 1994 Mar; 78(2):194-202. PubMed ID: 8119374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
    Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo.
    Sirotnak FM; Wendel HG; Bornmann WG; Tong WP; Miller VA; Scher HI; Kris MG
    Clin Cancer Res; 2000 Sep; 6(9):3705-12. PubMed ID: 10999764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.